Wolters Kluwer Partners with China’s NCID to Advance Infectious Disease Diagnosis
Holland-based information and software solutions provider Wolters Kluwer has announced a partnership with China’s National...
2022
Jiangxi Healthcare Security Administration Launches New VBP Tender
The Jiangxi Healthcare Security Administration (JHSA) has released a notice of a new volume-based procurement...
Fapon Biotech Partners with CR Pharma to Develop IVD Open Platform Ecosystem
China-based biotech Fapon Biotech Inc. has announced a partnership with China Resources Pharmaceutical Commercial Group...
Henlius’ Serplulimab Phase III Study Approved in Spain for LS-SCLC
China-based Shanghai Henlius Biotech (HKG: 2696) has announced that its global, multi-center Phase III clinical...
Hainan Poly Pharm Wins Finland Approval for Generic Cytovene-IV
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced receiving marketing approval from the...
Kangtai Biological Completes Phase III Clinical Data Analysis for COVID-19 Vaccine
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced the completion of the...
Jiangxi Leads 22-Province Alliance in VBP for Liver Function Test Reagents
The provincial drug and medical consumables centralized procurement joint meeting office of Jiangxi has released...
Fapon Biotech Partners with Roche Diagnostics at China International Import Expo
China-based biotech Fapon Biotech Inc. has announced a partnership with Swiss major Roche Diagnostics at...
China’s Jiangsu Bioda Gains NMPA Approval for Innovative Artificial Blood Vessel
The National Medical Products Administration (NMPA) has granted marketing approval to China-based Jiangsu Bioda Life...
Visen Pharmaceuticals Publishes Phase III Data for Lonapegsomatropin in Growth Hormone Deficiency
Visen Pharmaceuticals, a China-based joint venture between Denmark-headquartered Ascendis Pharma and Chinese healthcare-focused investment firm...
RongCan Biotech Raises Pre-Series A Funding for mRNA Therapeutics Development
China-based nucleic acid-based therapeutics developer RongCan (Shanghai) Biotech Co., Ltd has reportedly raised “tens of...
Lee’s Pharmaceutical Reports Q3 2022 Financials with 8.8% Revenue Growth
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) has released its Q3 2022 financial report, recording...
Marinus Pharmaceuticals Collaborates with Tenacia Biotechnology for Ganaxolone
Pennsylvania-based pharma company Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) has entered into a collaboration and supply...
Mirati Therapeutics Sues InventisBio Over Trade Secret Misappropriation
US-based Mirati Therapeutics (Nasdaq: MRTX) is reportedly suing China-based InventisBio Co., Ltd (SHA: 688382) over...
CDE Issues Trial Rules for NMPA Drug Review Timekeeping Suspension
The Center for Drug Evaluation (CDE) has released the “NMPA Drug Review Timekeeping Suspension and...
Bio-Heart Bio to Launch Clinical Study for Rapamycin Drug-Eluting Balloon in Japan
China-based Shanghai Bio-Heart Biological Technology Co., Ltd (HKG: 2185) has announced that it will initiate...
Bio-Heart Bio Receives Ethical Approval for Iberis RDN System in Hainan
China-based Shanghai Bio-Heart Biological Technology Co., Ltd (HKG: 2185) has announced receiving ethical approval from...
BeiGene’s Brukinsa Receives EC Approval for CLL Treatment
China-based biotech BeiGene Ltd. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) has announced receiving marketing approval...
Zhangjiang AI New Drug R&D Alliance Expands with New Members
The Zhangjiang AI New Drug R&D Alliance has welcomed new participants, including Regor Therapeutics, Roche,...
Subtle Medical Secures Series B Funding for AI-Powered Medical Imaging
Subtle Medical, an Artificial Intelligence (AI)-empowered medical imaging company based in Guangdong, has reportedly raised...